[go: up one dir, main page]

US3882862A - Arteriovenous shunt - Google Patents

Arteriovenous shunt Download PDF

Info

Publication number
US3882862A
US3882862A US432462A US43246274A US3882862A US 3882862 A US3882862 A US 3882862A US 432462 A US432462 A US 432462A US 43246274 A US43246274 A US 43246274A US 3882862 A US3882862 A US 3882862A
Authority
US
United States
Prior art keywords
shunt
tubular
arteriovenous shunt
blood
arteriovenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US432462A
Inventor
Olga Berend
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ING (US) Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US432462A priority Critical patent/US3882862A/en
Application granted granted Critical
Publication of US3882862A publication Critical patent/US3882862A/en
Anticipated expiration legal-status Critical
Assigned to ING (U.S.) CORPORATION reassignment ING (U.S.) CORPORATION (INVALID ASSIGNMENT) SEE RECORDING ON REEL 9534, FRAME 0084 ( ATTORNEY REFUSED TO CORRECT IMPROPER ASSIGNMENT) Assignors: MERIDIAN MEDICAL TECHNOLOGIES, INC.
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3655—Arterio-venous shunts or fistulae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/064—Blood vessels with special features to facilitate anastomotic coupling

Definitions

  • An arteriovenous shunt which utilizes Venturi principles to provide a turbulent-free blood flow of virtually constant velocity through the shunt for hemodialysis, or other purposes.
  • the embodiment to be described uses inlet and outlet cuffs which are sown to a severed artery and to a severed vein respectively, so as to receive blood from the artery and return the blood to the vein.
  • Venturi tubes are coupled to the cuffs, and associated tubing completes the shunt.
  • the Venturi tubes are located adjacent the inlet and outlet cuffs to provide turbulence-free blood flow at both ends of the shunt, thereby preventing clotting of the blood, and permitting the shunt to be used for extended periods of time.
  • the radial artery is usually cannulated in accordance with present day practice at a distance from the wrist to the antecubital fossa.
  • the exit end of the prior art shunt, as stated above, is usually inserted subcutaneously into an appropriate vein.
  • the usual prior art arteriovenous shunt includes an arterial cannula and a venous cannula which are respectively inserted into a selected artery and into a selected vein in the arm or leg of the patient, as described above.
  • the insertion of the prior art cannula due to the reduction in size of the orifice presented by the cannula, as compared with the corresponding blood vessel, creates a turbulent blood flow condition at both the entrance and the exit of the prior art shunt.
  • Such turbulence is instrumental in causing trauma and subsequent pathological conditions in the prior art shunt.
  • the turbulence is obviated in the embodiment of the invention to be described by integrating Venturi tubes at each end of the shunt of the invention, and by coupling the Venturi tubes to the corresponding blood vessels by appropriate cuffs which, as will be described, are sutured to the blood vessels.
  • FIG. I is a somewhat schematic representation of an arteriovenous shunt constructed in accordance with the concepts of the invention and shown in its shunted condition between hemodialysis treatments;
  • FIG. 2 is a schematic representation of the shunt of FIG. 1 intercoupled to a dialyzer for a dialysis treatment of the patient;
  • FIG. 3 is a representation of the cross section of the entrance of a prior art shunt, and illustrates the result ing turbulence, and associated pressure curve;
  • FIG. 4 is a cross sectional representation of the entrance of another prior art shunt, also showing the resulting turbulence and associated pressure curve;
  • FIG. 5 is a representation of the entrance to the shunt of the present invention, and showing the resulting smooth flow of the blood at the entrance and exit of the shunt, and associated pressure curve.
  • the arteriovenous shunt of the embodiment of the invention shown in FIG. 1 comprises a first Venturi tube 10 which may, for example, be formed of hard silastic material, and which is molded to a piece of flexible silastic tubing 12.
  • the remote end of the silastic tubing 12 may be terminated in the female portion 141; of a beveled connector 14 which, likewise, may be formed of hard silastic material.
  • Both the Venturi tube 10 and the portion 14a of the connector 14 may be integrated with the flexible silastic tubing 12.
  • the Venturi tube 10 is attached to a short cuff 16 formed, for example, of seamless woven Dacron. Care should be taken that the mating inner surfaces of the cuff 16 and Venturi tube 10 are smoothly formed.
  • the other end of the cuff 16 is sutured to a separate artery 18 in the arm or leg of the patient to receive blood from the artery.
  • the end of the cuff 16 adjacent the artery is heat treated to offer a smooth surface to the blood flow.
  • a continuous over-and-over suture of 5-0 or 6-0 arterial silk should be used.
  • a similar Venturi tube 20 is formed in the end of a second piece of flexible silastic tubing 22, the throat of the Venturi tube 20 extending in the opposite direction to the throat of the Venturi tube 10.
  • the Venturi tube 20 is attached to a cuff 22 which, likewise, may be formed of Dacron, and the attachment is made in the same manner as described above.
  • the cuff 22 is su tured to a vein 24 which receives blood from the shunt.
  • the suture 26 between the cuff 22 and the vein 24 may be the same as the suture 28 between the artery 18 and cuff 16.
  • the ratio of the inside diameter of the cuffs 16, 22 and the respective blood vessels 18, 24 should be of the order of l.5:l.0.
  • the tube 22 is attached to the male portion 14b of the beveled connector 14 which may be formed of hardened silastic material integral with the end of the tubing 22, as may the Venturi tube 20.
  • An outlet 30 may be formed in the tubing 22. The outlet 30 may be plugged by an appropriate stopper 32.
  • the shunt of the invention may take the form of a single piece of silastic tubing between the Venturi tubes 10 and 20, with two outlets such as the outlet 30 formed at spaced position along the tubing.
  • This provides a structure similar in some respects to the Buselmeier shunt described in the publication Dialysis and Transplantation, for August/September 1973.
  • the shunt may incorporate the connector 14, as shown in FIG. 1, and which may be easily separated to permit a pump 50 and dializer 52 (FIG. 2) to be included in the circulating path of the shunt during the dialysis treatment.
  • the shunt of the invention provides a smooth constant internal cross section when so connected.
  • a direct arteriovenous fistula is not feasable for many patients. These reasons include, for example, the need for immediate usage, cardiac pathology, distal ischemia, vascular inadequacy, venous aneurysmes, venous damage due to repeated venipuncture, extensive intraluminal clotting or repeated infiltration, and so on.
  • the shunt of the invention will, in the course of usage, be lined by a thin layer of fibrous tissue and endothelium, the hemodynamic characteristics of the shunt, due to the unique features of the Venturi tubes, provide a resulting flowfield superior to an arteriovenous fistula, and yet being applicable under the various conditions outlined above, in which the direct arteriovenous fistula is not feasable,
  • the insertion of the cannulas of the prior art arteriovenous shunts due to the reduction in size of the orifices, creates a turbulent flow of the blood, both at the entrance and at the exit of the prior art shunts.
  • the resulting stress in the prior art shunt is instrumental in causing intimal trauma and subsequent undesirable pathological conditions.
  • FIGS. 3 and 4 The flow-fields of the blood in the prior art shunts, and related pressure drops, are shown in FIGS. 3 and 4.
  • the representation A in FIG. 3 shows the flow-field in a rounded approach orifice
  • the representation A in FIG. 4 shows the flow-field in a sharp edge approach orifice, in the prior art type of shunts.
  • Each of the orifices of FIGS. 3 and 4 show considerable turbulence.
  • each of the prior art orifices show a relatively high pressure drop, as illustrated by the curves B in FIG. 3 and 4.
  • the entrance flow velocity (w) at the orifice cross section (a) is:
  • A is the blood vessel cross section
  • p is the pressure in the blood vessel
  • p is the pressure at the orifice exit
  • S is specific density of the blood.
  • the exit flow velocity (w at the cross section B of the prior art cannulus can be calculated by the same equation.
  • the pressure drop in the prior art assemblies is 60-70% when compared with the entry orifice pressure, and consequently there is an undesirable increase in exit flow velocity w,, in the prior art structures due to the disturbed flow'field, as shown in FIGS. 3 and 4.
  • the diameter of the Venturi tubes 10 and 20 can be selected to match the difference in diameters between the artery 18 and vein 24, so that, in each instance, an undisturbed fluid flow may be achieved both at the entrance and at the exit of the shunt.
  • the ends of the shunt which penetrate the skin may be enclosed in Teflon casings of roughened outer surfaces, so as to lessen the danger of infection, to promote tissue ingrowth, and to effect a firm mechanical seal.
  • the invention provides, therefore, an improved arteriovenous shunt which has certain advantages over built in fistula in the elimination of the maturity period, and of the necessity for needle penetration during hemodialysis.
  • An arteriovenous shunt for hemodialysis patients, and the like comprising: elongated tubular means having an entrance end and an exit end creating a fluidcirculating path between the entrance end and the exit end; an elongated tube having one end attached to the entrance end of said elongated tubular means and having an inner surface flared outwardly from the other end thereof towards said one end to create a Venturi effect and thereby prevent turbulence in the fluid circulating therethrough; and a flexible tubular cuff having one end attached to the other end of said elongated tube and having an outwardly flared opposite end to be sutured to a severed duct in the body of the patient.
  • arteriovenous shunt defined in claim 1, in which said tubular means is formed of flexible silastic tubing and said tube is formed of hard silastic material, and in which said cuff is formed of a plastice fabric material.
  • tubular means comprises a first tubular member and a second tubular member, and separable connector means intercoupling said first and second tubular members.
  • arteriovenous shunt defined in claim 1, and which includes at least one outlet formed in said tubular means.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)

Abstract

An arteriovenous shunt is provided which utilizes Venturi principles to provide a turbulent-free blood flow of virtually constant velocity through the shunt for hemodialysis, or other purposes. The embodiment to be described uses inlet and outlet cuffs which are sown to a severed artery and to a severed vein respectively, so as to receive blood from the artery and return the blood to the vein. Venturi tubes are coupled to the cuffs, and associated tubing completes the shunt. The Venturi tubes are located adjacent the inlet and outlet cuffs to provide turbulence-free blood flow at both ends of the shunt, thereby preventing clotting of the blood, and permitting the shunt to be used for extended periods of time.

Description

United States Patent 1191 Berend I ARTERIOVENOUS SHUNT [76] Inventor: Olga Berend, 631 l Drexel Ave., Los
Angeles, Calif. 90048 22 Filed: Jan.ll,1974
21 AppI.No.:432,462
OTHER PUBLICATIONS Goldberg et a1. Trans. Amer. Soc. Artific. Inter. Orgs, 1972, Vol. XVIII, pp. 441447.
[ 1 May 13, 1975 Primary Eranziner-Dalton L. Truluck Attorney, Agent, or Firm-Jessup & Beecher [57] ABSTRACT An arteriovenous shunt is provided which utilizes Venturi principles to provide a turbulent-free blood flow of virtually constant velocity through the shunt for hemodialysis, or other purposes. The embodiment to be described uses inlet and outlet cuffs which are sown to a severed artery and to a severed vein respectively, so as to receive blood from the artery and return the blood to the vein. Venturi tubes are coupled to the cuffs, and associated tubing completes the shunt. The Venturi tubes are located adjacent the inlet and outlet cuffs to provide turbulence-free blood flow at both ends of the shunt, thereby preventing clotting of the blood, and permitting the shunt to be used for extended periods of time.
5 Claims, 5 Drawing Figures PATENTEB MAY 1 3 I975 SHEET 10F 2 SHEU 20? 2 PAH-INTEL] MAY 1 3%975 ARTERIOVENOUS SHUNT BACKGROUND OF THE INVENTION The placement of indwelling arterial and venous cannulas in the arm or leg of a patient for hemodialysis purposes, and which are shunted when not in use, is a technique which is known to the art. This technique enables multiple hemodialysis treatments to be made from a single cannulation. It is usual in the prior art to insert the entrance end of the cannula percutaneously into an artery, and to insert the exit end of the cannula percutaneously into a vein, in the arm or leg of the patient. The radial artery is usually cannulated in accordance with present day practice at a distance from the wrist to the antecubital fossa. The exit end of the prior art shunt, as stated above, is usually inserted subcutaneously into an appropriate vein.
The longevity of the indwelling prior art cannulas is, in part, determined by the susceptibility of the blood dirculating through the cannulas to turbulence and resulting clotting. However, the success of such a shunt depends on a long term use thereof, if it is to be of any substantial aid to patients with chronic renal disease who require long-term intermittent hemodialysis. In the last years there has been extensive experience in the field, and many improvements in the implanting techniques of arteriovenous shunts for chronic hemodialysis patients have resulted.
Malfunctions of the prior art arteriovenous shunts are contributable generally to blood clotting, intimal damage caused by insertion or frictional trauma, angulation, phlebitic narrowing, and aneurysms. While some of the malfunctions can, at least be temporarily alleviated or controlled in the prior art shunts, the life sustaining nature of this prosthesis stimulated the more reliable and durable shunt of the present invention. The prior art shunts have suffered from a relatively short clot-free life time on the order of 29 days, and even with heparin treatments the average life time of the prior art shunt does not exceed 2.7 months.
The usual prior art arteriovenous shunt includes an arterial cannula and a venous cannula which are respectively inserted into a selected artery and into a selected vein in the arm or leg of the patient, as described above. The insertion of the prior art cannula, due to the reduction in size of the orifice presented by the cannula, as compared with the corresponding blood vessel, creates a turbulent blood flow condition at both the entrance and the exit of the prior art shunt. Such turbulence is instrumental in causing trauma and subsequent pathological conditions in the prior art shunt.
The turbulence is obviated in the embodiment of the invention to be described by integrating Venturi tubes at each end of the shunt of the invention, and by coupling the Venturi tubes to the corresponding blood vessels by appropriate cuffs which, as will be described, are sutured to the blood vessels.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. I is a somewhat schematic representation of an arteriovenous shunt constructed in accordance with the concepts of the invention and shown in its shunted condition between hemodialysis treatments;
FIG. 2 is a schematic representation of the shunt of FIG. 1 intercoupled to a dialyzer for a dialysis treatment of the patient;
FIG. 3 is a representation of the cross section of the entrance of a prior art shunt, and illustrates the result ing turbulence, and associated pressure curve;
FIG. 4 is a cross sectional representation of the entrance of another prior art shunt, also showing the resulting turbulence and associated pressure curve; and
FIG. 5 is a representation of the entrance to the shunt of the present invention, and showing the resulting smooth flow of the blood at the entrance and exit of the shunt, and associated pressure curve.
DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENT The arteriovenous shunt of the embodiment of the invention shown in FIG. 1 comprises a first Venturi tube 10 which may, for example, be formed of hard silastic material, and which is molded to a piece of flexible silastic tubing 12. The remote end of the silastic tubing 12 may be terminated in the female portion 141; of a beveled connector 14 which, likewise, may be formed of hard silastic material. Both the Venturi tube 10 and the portion 14a of the connector 14 may be integrated with the flexible silastic tubing 12.
The Venturi tube 10 is attached to a short cuff 16 formed, for example, of seamless woven Dacron. Care should be taken that the mating inner surfaces of the cuff 16 and Venturi tube 10 are smoothly formed. The other end of the cuff 16 is sutured to a separate artery 18 in the arm or leg of the patient to receive blood from the artery. The end of the cuff 16 adjacent the artery is heat treated to offer a smooth surface to the blood flow. A continuous over-and-over suture of 5-0 or 6-0 arterial silk should be used.
A similar Venturi tube 20 is formed in the end of a second piece of flexible silastic tubing 22, the throat of the Venturi tube 20 extending in the opposite direction to the throat of the Venturi tube 10. The Venturi tube 20 is attached to a cuff 22 which, likewise, may be formed of Dacron, and the attachment is made in the same manner as described above. The cuff 22 is su tured to a vein 24 which receives blood from the shunt. The suture 26 between the cuff 22 and the vein 24 may be the same as the suture 28 between the artery 18 and cuff 16. For optimum hemodynamic efficiency, the ratio of the inside diameter of the cuffs 16, 22 and the respective blood vessels 18, 24 should be of the order of l.5:l.0.
The tube 22 is attached to the male portion 14b of the beveled connector 14 which may be formed of hardened silastic material integral with the end of the tubing 22, as may the Venturi tube 20. An outlet 30 may be formed in the tubing 22. The outlet 30 may be plugged by an appropriate stopper 32.
The shunt of the invention, as an alternative, may take the form of a single piece of silastic tubing between the Venturi tubes 10 and 20, with two outlets such as the outlet 30 formed at spaced position along the tubing. This provides a structure similar in some respects to the Buselmeier shunt described in the publication Dialysis and Transplantation, for August/September 1973. Alternately, the shunt may incorporate the connector 14, as shown in FIG. 1, and which may be easily separated to permit a pump 50 and dializer 52 (FIG. 2) to be included in the circulating path of the shunt during the dialysis treatment. The shunt of the invention provides a smooth constant internal cross section when so connected.
For various reasons, a direct arteriovenous fistula is not feasable for many patients. These reasons include, for example, the need for immediate usage, cardiac pathology, distal ischemia, vascular inadequacy, venous aneurysmes, venous damage due to repeated venipuncture, extensive intraluminal clotting or repeated infiltration, and so on. However, since the shunt of the invention will, in the course of usage, be lined by a thin layer of fibrous tissue and endothelium, the hemodynamic characteristics of the shunt, due to the unique features of the Venturi tubes, provide a resulting flowfield superior to an arteriovenous fistula, and yet being applicable under the various conditions outlined above, in which the direct arteriovenous fistula is not feasable,
As mentioned above, the insertion of the cannulas of the prior art arteriovenous shunts, due to the reduction in size of the orifices, creates a turbulent flow of the blood, both at the entrance and at the exit of the prior art shunts. The resulting stress in the prior art shunt is instrumental in causing intimal trauma and subsequent undesirable pathological conditions.
The flow-fields of the blood in the prior art shunts, and related pressure drops, are shown in FIGS. 3 and 4. The representation A in FIG. 3 shows the flow-field in a rounded approach orifice, and the representation A in FIG. 4 shows the flow-field in a sharp edge approach orifice, in the prior art type of shunts. Each of the orifices of FIGS. 3 and 4 show considerable turbulence. Moreover, each of the prior art orifices show a relatively high pressure drop, as illustrated by the curves B in FIG. 3 and 4.
According to Bernouilis equation, the entrance flow velocity (w) at the orifice cross section (a) is:
where: A is the blood vessel cross section; p is the pressure in the blood vessel; p is the pressure at the orifice exit; and S is specific density of the blood. The exit flow velocity (w at the cross section B of the prior art cannulus can be calculated by the same equation.
As shown in the illustrated examples of FIGS. 3 and 4, the pressure drop in the prior art assemblies is 60-70% when compared with the entry orifice pressure, and consequently there is an undesirable increase in exit flow velocity w,, in the prior art structures due to the disturbed flow'field, as shown in FIGS. 3 and 4.
When Venturi tubes and are used in the shunt of the present invention, the resulting flow-field is smooth with minimum turbulence, as shown in the rep resentation A of FIG. 5. Moreover, as shown by the curve B of FIG. 5, practically all the pressure drop is recovered at the exit of the Venturi tube. Thus, the case where the cross sectional area A approximately equals the cross sectional are B, in the representation A of FIG. 5, then an almost constant flow velocity will result, so that turbulence will be avoided.
The diameter of the Venturi tubes 10 and 20 can be selected to match the difference in diameters between the artery 18 and vein 24, so that, in each instance, an undisturbed fluid flow may be achieved both at the entrance and at the exit of the shunt. The ends of the shunt which penetrate the skin may be enclosed in Teflon casings of roughened outer surfaces, so as to lessen the danger of infection, to promote tissue ingrowth, and to effect a firm mechanical seal. Such a technique is described, for example, in an article by R. A. Ersek et al., entitled A New Arteriovenous Shunt Design appearing in the transactions of the American Society of Artificial Organs 15:267, 1969.
The invention provides, therefore, an improved arteriovenous shunt which has certain advantages over built in fistula in the elimination of the maturity period, and of the necessity for needle penetration during hemodialysis.
It will be appreciated that although particular embodiments of the invention have been shown and described, modifications may be made. It is intended in the claims to cover the modifications which come within the spirit and scope of the invention.
What is claimed:
1. An arteriovenous shunt for hemodialysis patients, and the like, comprising: elongated tubular means having an entrance end and an exit end creating a fluidcirculating path between the entrance end and the exit end; an elongated tube having one end attached to the entrance end of said elongated tubular means and having an inner surface flared outwardly from the other end thereof towards said one end to create a Venturi effect and thereby prevent turbulence in the fluid circulating therethrough; and a flexible tubular cuff having one end attached to the other end of said elongated tube and having an outwardly flared opposite end to be sutured to a severed duct in the body of the patient.
2. The arteriovenous shunt defined in claim 1, in which said tubular means is formed of flexible silastic tubing and said tube is formed of hard silastic material, and in which said cuff is formed of a plastice fabric material.
3. The arteriovenous shunt defined in claim 1, and which includes a second elongated tube having one end connected to the exit end of said tubular means, and having an inner surface flared outwardly toward the other end thereof to create a Venturi effect and thereby prevent turbulence in the fluid circulating therethrough.
4. The arteriovenous shunt defined in claim 1, in which said tubular means comprises a first tubular member and a second tubular member, and separable connector means intercoupling said first and second tubular members.
5. The arteriovenous shunt defined in claim 1, and which includes at least one outlet formed in said tubular means.

Claims (5)

1. An arteriovenous shunt for hemodialysis patients, and the like, comprising: elongated tubular means having an entrance end and an exit end creating a fluid-circulating path between the entrance end and the exit end; an elongated tube having one end attached to the entrance end of said elongated tubular means and having an inner surface flared outwardly from the other end thereof towards said one end to create a Venturi effect and thereby prevent turbulence in the fluid circulating therethrough; and a flexible tubular cuff having one end attached to the other end of said elongated tube and having an outwardly flared opposite end to be sutured to a severed duct in the body of the patient.
2. The arteriovenous shunt defined in claim 1, in which said tubular means is formed of flexible silastic tubing and said tube is formed of hard silastic material, and in which said cuff is formed of a plastice fabric material.
3. The arteriovenous shunt defined in claim 1, and which includes a second elongated tube having one end connected to the exit end of said tubular means, and having an inner surface flared outwardly toward the other end thereof to create a Venturi effect and thereby prevent turbulence in the fluid circulating therethrough.
4. The arteriovenous shunt defined in claim 1, in which said tubular means comprises a first tubular member and a second tubular member, and separable connector means intercoupling said first and second tubular members.
5. The arteriovenous shunt defined in claim 1, and which includes at least one outlet formed in said tubular means.
US432462A 1974-01-11 1974-01-11 Arteriovenous shunt Expired - Lifetime US3882862A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US432462A US3882862A (en) 1974-01-11 1974-01-11 Arteriovenous shunt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US432462A US3882862A (en) 1974-01-11 1974-01-11 Arteriovenous shunt

Publications (1)

Publication Number Publication Date
US3882862A true US3882862A (en) 1975-05-13

Family

ID=23716264

Family Applications (1)

Application Number Title Priority Date Filing Date
US432462A Expired - Lifetime US3882862A (en) 1974-01-11 1974-01-11 Arteriovenous shunt

Country Status (1)

Country Link
US (1) US3882862A (en)

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998222A (en) * 1974-04-15 1976-12-21 Shihata Alfred A Subcutaneous arterio-venous shunt with valve
US4133312A (en) * 1976-10-13 1979-01-09 Cordis Dow Corp. Connector for attachment of blood tubing to external arteriovenous shunts and fistulas
EP0128215A1 (en) * 1982-12-13 1984-12-19 Possis Medical Inc Vascular graft and blood supply method.
US4586919A (en) * 1984-04-06 1986-05-06 Taheri Syde A External shunt and method for procuring and preserving the endothelium of a vein used in arterial bypass
US4607637A (en) * 1983-07-22 1986-08-26 Anders Berggren Surgical instrument for performing anastomosis with the aid of ring-like fastening elements and the fastening elements for performing anastomosis
US4624257A (en) * 1982-06-24 1986-11-25 Anders Berggren Surgical instrument for performing anastomosis
US4669463A (en) * 1984-02-22 1987-06-02 Mcconnell Richard B Endotracheal tube injection site addition
US4892518A (en) * 1987-12-04 1990-01-09 Biocontrol Technology, Inc. Hemodialysis
US4979937A (en) * 1987-12-22 1990-12-25 Khorasani Ahmad R Method and apparatus involving intercostal and lumbar perfusion
WO1993002637A1 (en) * 1991-08-01 1993-02-18 Polymedica Industries, Inc. Vascular prosthesis
WO1998044869A1 (en) * 1997-04-05 1998-10-15 The Queen's University Of Belfast Haemodynamic control device
US5879321A (en) * 1997-01-22 1999-03-09 The University Of Kentucky Research Foundation Portocaval-right atrial shunt
WO1999065559A1 (en) * 1998-06-19 1999-12-23 Klinični center Ljubljana Hose for making an artificial vessel
US6059745A (en) * 1997-05-20 2000-05-09 Gelbfish; Gary A. Thrombectomy device and associated method
WO2000015275A3 (en) * 1998-09-10 2000-08-10 Percardia Inc Body fluid shunt device and method of use
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6338724B1 (en) 1999-03-29 2002-01-15 Christos D. Dossa Arterio-venous interconnection
US6592567B1 (en) 1999-12-07 2003-07-15 Chf Solutions, Inc. Kidney perfusion catheter
US20040087997A1 (en) * 2002-08-09 2004-05-06 Theracardia, Inc. Medical devices incorporating elastically deformable SIM elements
US20040210302A1 (en) * 1998-12-08 2004-10-21 Bard Peripheral Vascular Flanged graft for end-to-side anastomosis
WO2004091696A1 (en) * 2003-04-08 2004-10-28 The Board Of Trustees Of The Leland Stanford Junior University Implantable arteriovenous shunt device
US20050137614A1 (en) * 2003-10-08 2005-06-23 Porter Christopher H. System and method for connecting implanted conduits
US20050159696A1 (en) * 2004-01-21 2005-07-21 Steven Bernard Tapered tubing for use in extracorporeal circuit for peripheral vein fluid removal
US20050277967A1 (en) * 2004-06-14 2005-12-15 Rox Medical, Inc. Methods for providing oxygenated blood to venous circulation
US20060030935A1 (en) * 1996-02-28 2006-02-09 Bard Peripheral Vascular, Inc. Flanged graft for end-to-side anastomosis
US20060047337A1 (en) * 2004-08-27 2006-03-02 Brenneman Rodney A Device and method for establishing an artificial arterio-venous fistula
US20060064159A1 (en) * 2003-10-08 2006-03-23 Porter Christopher H Device and method for vascular access
US20060111704A1 (en) * 2004-11-22 2006-05-25 Rox Medical, Inc. Devices, systems, and methods for energy assisted arterio-venous fistula creation
US20060129083A1 (en) * 2004-12-15 2006-06-15 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US20060206123A1 (en) * 2004-08-27 2006-09-14 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20070005128A1 (en) * 2005-07-01 2007-01-04 C. R. Bard, Inc. Flanged graft with trim lines
US20070123811A1 (en) * 1997-02-07 2007-05-31 Squitieri Rafael P Squitieri hemodialysis and vascular access systems
US20070239180A1 (en) * 2006-04-06 2007-10-11 Synovis Life Technologies, Inc. Method and assembly for anastomosis
US20070249985A1 (en) * 2004-08-27 2007-10-25 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20070299384A1 (en) * 2003-04-08 2007-12-27 The Board Of Regents Of The Leland Stanford Junior University Implantable arterio-venous shunt devices and methods for their use
US20080077070A1 (en) * 2006-08-10 2008-03-27 Kopia Gregory A Arteriovenous shunt
US20090192469A1 (en) * 2008-01-24 2009-07-30 Istvan Bognar Devices and Methods for Development of a Scar Tissue Tunnel Track
US20100130835A1 (en) * 2008-09-30 2010-05-27 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
US20100280598A1 (en) * 2007-12-27 2010-11-04 C.R. Bard, Inc. Vascular graft prosthesis having a reinforced margin for enhanced anastomosis
US8079973B2 (en) 2008-03-05 2011-12-20 Hemosphere Inc. Vascular access system
US20120041270A1 (en) * 2007-06-29 2012-02-16 Applied Medical Technology, Inc. Molded and undivided medical penetrating device
US20140142566A1 (en) * 2011-06-28 2014-05-22 Safeair Ag Coupling means connecting an electrosurgical instrument to a vacuum source, an electrosurgical instrument provided with the coupling means, a kit including the coupling means and their uses
US9278172B2 (en) 2011-09-06 2016-03-08 Cryolife, Inc. Vascular access system with connector
US9445886B2 (en) 1997-05-17 2016-09-20 Bard Peripheral Vascular, Inc. Vascular prosthesis
WO2017046628A1 (en) 2015-09-15 2017-03-23 Koninklijke Philips N.V. Device and method for using ivus data to characterize and evaluate a vascular graft condition
US9814869B1 (en) 1999-06-15 2017-11-14 C.R. Bard, Inc. Graft-catheter vascular access system
US10034739B2 (en) 2012-06-18 2018-07-31 Board Of Regents Of The University Of Nebraska Stent to assist in arteriovenous fistula formation
US10433847B2 (en) 2013-12-17 2019-10-08 The Board Of Regents Of The University Of Nebraska Platform device and method of use to assist in anastomosis formation
US10682453B2 (en) 2013-12-20 2020-06-16 Merit Medical Systems, Inc. Vascular access system with reinforcement member
US10792413B2 (en) 2008-03-05 2020-10-06 Merit Medical Systems, Inc. Implantable and removable customizable body conduit
US10925710B2 (en) 2017-03-24 2021-02-23 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11026704B2 (en) 2017-03-06 2021-06-08 Merit Medical Systems, Inc. Vascular access assembly declotting systems and methods
US11179543B2 (en) 2017-07-14 2021-11-23 Merit Medical Systems, Inc. Releasable conduit connectors
US11331458B2 (en) 2017-10-31 2022-05-17 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11383072B2 (en) 2017-01-12 2022-07-12 Merit Medical Systems, Inc. Methods and systems for selection and use of connectors between conduits
US11413043B2 (en) 2016-11-10 2022-08-16 Merit Medical Systems, Inc. Anchor device for vascular anastomosis
US11590010B2 (en) 2017-01-25 2023-02-28 Merit Medical Systems, Inc. Methods and systems for facilitating laminar flow between conduits
US11911585B2 (en) 2017-07-20 2024-02-27 Merit Medical Systems, Inc. Methods and systems for coupling conduits

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3638649A (en) * 1969-07-07 1972-02-01 Univ Minnesota Implantable prosthetic pass-through device
US3713441A (en) * 1970-10-22 1973-01-30 Battelle Development Corp Method of using an artery vein shunt applique
US3818511A (en) * 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3638649A (en) * 1969-07-07 1972-02-01 Univ Minnesota Implantable prosthetic pass-through device
US3713441A (en) * 1970-10-22 1973-01-30 Battelle Development Corp Method of using an artery vein shunt applique
US3818511A (en) * 1972-11-17 1974-06-25 Medical Prod Corp Medical prosthesis for ducts or conduits

Cited By (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998222A (en) * 1974-04-15 1976-12-21 Shihata Alfred A Subcutaneous arterio-venous shunt with valve
US4133312A (en) * 1976-10-13 1979-01-09 Cordis Dow Corp. Connector for attachment of blood tubing to external arteriovenous shunts and fistulas
US4624257A (en) * 1982-06-24 1986-11-25 Anders Berggren Surgical instrument for performing anastomosis
US4917090A (en) * 1982-06-24 1990-04-17 Unilink, Inc. Method for performing an anastomosis
DE3390385C2 (en) * 1982-12-13 1994-07-07 Possis Medical Inc Vascular implants
EP0128215A1 (en) * 1982-12-13 1984-12-19 Possis Medical Inc Vascular graft and blood supply method.
EP0128215A4 (en) * 1982-12-13 1986-07-17 Possis Medical Inc Vascular graft and blood supply method.
US4607637A (en) * 1983-07-22 1986-08-26 Anders Berggren Surgical instrument for performing anastomosis with the aid of ring-like fastening elements and the fastening elements for performing anastomosis
US4669463A (en) * 1984-02-22 1987-06-02 Mcconnell Richard B Endotracheal tube injection site addition
US4586919A (en) * 1984-04-06 1986-05-06 Taheri Syde A External shunt and method for procuring and preserving the endothelium of a vein used in arterial bypass
US4892518A (en) * 1987-12-04 1990-01-09 Biocontrol Technology, Inc. Hemodialysis
US4979937A (en) * 1987-12-22 1990-12-25 Khorasani Ahmad R Method and apparatus involving intercostal and lumbar perfusion
WO1992005815A1 (en) * 1989-10-02 1992-04-16 Ahmad Rajaii Khorasani Method and apparatus involving intercostal and lumbar perfusion
WO1993002637A1 (en) * 1991-08-01 1993-02-18 Polymedica Industries, Inc. Vascular prosthesis
US20060030935A1 (en) * 1996-02-28 2006-02-09 Bard Peripheral Vascular, Inc. Flanged graft for end-to-side anastomosis
US9028539B2 (en) 1996-02-28 2015-05-12 Bard Peripheral Vascular, Inc. Flanged graft for end-to-side anastomosis
US5879321A (en) * 1997-01-22 1999-03-09 The University Of Kentucky Research Foundation Portocaval-right atrial shunt
USRE44639E1 (en) 1997-02-07 2013-12-10 Hemosphere, Inc. Hemodialysis and vascular access system
US20070123811A1 (en) * 1997-02-07 2007-05-31 Squitieri Rafael P Squitieri hemodialysis and vascular access systems
USRE41448E1 (en) 1997-02-07 2010-07-20 Hemosphere, Inc. Squitieri hemodialysis and vascular access systems
WO1998044869A1 (en) * 1997-04-05 1998-10-15 The Queen's University Of Belfast Haemodynamic control device
US9445886B2 (en) 1997-05-17 2016-09-20 Bard Peripheral Vascular, Inc. Vascular prosthesis
US6059745A (en) * 1997-05-20 2000-05-09 Gelbfish; Gary A. Thrombectomy device and associated method
WO1999065559A1 (en) * 1998-06-19 1999-12-23 Klinični center Ljubljana Hose for making an artificial vessel
US6409751B1 (en) 1998-09-10 2002-06-25 Percardia, Inc. Stent delivery system and method of use
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
WO2000015275A3 (en) * 1998-09-10 2000-08-10 Percardia Inc Body fluid shunt device and method of use
US20040210302A1 (en) * 1998-12-08 2004-10-21 Bard Peripheral Vascular Flanged graft for end-to-side anastomosis
US7553316B2 (en) 1998-12-08 2009-06-30 Bard Peripheral Vascular, Inc. Flanged graft for end-to-side anastomosis
US6338724B1 (en) 1999-03-29 2002-01-15 Christos D. Dossa Arterio-venous interconnection
US9993633B2 (en) 1999-06-15 2018-06-12 C. R. Bard, Inc. Graft-catheter vascular access system
US9814869B1 (en) 1999-06-15 2017-11-14 C.R. Bard, Inc. Graft-catheter vascular access system
US6592567B1 (en) 1999-12-07 2003-07-15 Chf Solutions, Inc. Kidney perfusion catheter
US20040087997A1 (en) * 2002-08-09 2004-05-06 Theracardia, Inc. Medical devices incorporating elastically deformable SIM elements
WO2004091696A1 (en) * 2003-04-08 2004-10-28 The Board Of Trustees Of The Leland Stanford Junior University Implantable arteriovenous shunt device
US7628768B2 (en) 2003-04-08 2009-12-08 Rox Medical, Inc. Implantable arterio-venous shunt devices and methods for their use
US20070299384A1 (en) * 2003-04-08 2007-12-27 The Board Of Regents Of The Leland Stanford Junior University Implantable arterio-venous shunt devices and methods for their use
US7967769B2 (en) 2003-04-08 2011-06-28 Rox Medical Inc. Implantable arterio-venous shunt devices and methods for their use
US20040249335A1 (en) * 2003-04-08 2004-12-09 Faul John L. Implantable arteriovenous shunt device
US8690815B2 (en) 2003-10-08 2014-04-08 Hemosphere, Inc. Device and method for vascular access
US20050137614A1 (en) * 2003-10-08 2005-06-23 Porter Christopher H. System and method for connecting implanted conduits
US20060064159A1 (en) * 2003-10-08 2006-03-23 Porter Christopher H Device and method for vascular access
US20110060264A1 (en) * 2003-10-08 2011-03-10 Hemosphere Inc. Device and method for vascular access
US7762977B2 (en) 2003-10-08 2010-07-27 Hemosphere, Inc. Device and method for vascular access
USRE47154E1 (en) 2003-10-08 2018-12-11 Merit Medical Systems, Inc. Device and method for vascular access
US20050159696A1 (en) * 2004-01-21 2005-07-21 Steven Bernard Tapered tubing for use in extracorporeal circuit for peripheral vein fluid removal
US8016782B2 (en) 2004-06-14 2011-09-13 Rox Medical, Inc. Methods for providing oxygenated blood to venous circulation
US20050277967A1 (en) * 2004-06-14 2005-12-15 Rox Medical, Inc. Methods for providing oxygenated blood to venous circulation
US8641747B2 (en) 2004-06-14 2014-02-04 Rox Medical, Inc. Devices for arterio-venous fistula creation
US8236014B2 (en) 2004-06-14 2012-08-07 Rox Medical, Inc. Methods for arterio-venous fistula creation
US20050277964A1 (en) * 2004-06-14 2005-12-15 Rox Medical, Inc. Methods for arterio-venous fistula creation
US20060047337A1 (en) * 2004-08-27 2006-03-02 Brenneman Rodney A Device and method for establishing an artificial arterio-venous fistula
US8273095B2 (en) 2004-08-27 2012-09-25 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20070249985A1 (en) * 2004-08-27 2007-10-25 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US10098643B2 (en) 2004-08-27 2018-10-16 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9468441B2 (en) 2004-08-27 2016-10-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8088171B2 (en) 2004-08-27 2012-01-03 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9820745B2 (en) 2004-08-27 2017-11-21 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US7828814B2 (en) 2004-08-27 2010-11-09 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US10751057B2 (en) 2004-08-27 2020-08-25 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US8734472B2 (en) 2004-08-27 2014-05-27 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9510832B2 (en) 2004-08-27 2016-12-06 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9706997B2 (en) 2004-08-27 2017-07-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8523800B2 (en) 2004-08-27 2013-09-03 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8932341B2 (en) 2004-08-27 2015-01-13 Rox Medical, Inc. Method for establishing an artificial arterio-venous fistula
US20090275876A1 (en) * 2004-08-27 2009-11-05 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20060206123A1 (en) * 2004-08-27 2006-09-14 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US9023097B2 (en) 2004-08-27 2015-05-05 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20060111704A1 (en) * 2004-11-22 2006-05-25 Rox Medical, Inc. Devices, systems, and methods for energy assisted arterio-venous fistula creation
US8226592B2 (en) 2004-12-15 2012-07-24 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US9669148B2 (en) 2004-12-15 2017-06-06 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US9011362B2 (en) * 2004-12-15 2015-04-21 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US20060129083A1 (en) * 2004-12-15 2006-06-15 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US8709069B2 (en) 2005-07-01 2014-04-29 C. R. Bard, Inc. Flanged graft with trim lines
US9532865B2 (en) 2005-07-01 2017-01-03 C.R. Bard, Inc. Trimming apparatus
US20070005128A1 (en) * 2005-07-01 2007-01-04 C. R. Bard, Inc. Flanged graft with trim lines
US10172702B2 (en) 2005-07-01 2019-01-08 C. R. Bard, Inc. Trimming apparatus
US8313013B2 (en) 2006-04-06 2012-11-20 Synovis Life Technologies, Inc. Method and assembly for anastomosis
US20070239180A1 (en) * 2006-04-06 2007-10-11 Synovis Life Technologies, Inc. Method and assembly for anastomosis
US20080077070A1 (en) * 2006-08-10 2008-03-27 Kopia Gregory A Arteriovenous shunt
US8382664B2 (en) * 2007-06-29 2013-02-26 Applied Medical Technology, Inc. Molded and undivided medical penetrating device
US20120041270A1 (en) * 2007-06-29 2012-02-16 Applied Medical Technology, Inc. Molded and undivided medical penetrating device
US20100280598A1 (en) * 2007-12-27 2010-11-04 C.R. Bard, Inc. Vascular graft prosthesis having a reinforced margin for enhanced anastomosis
US20090192469A1 (en) * 2008-01-24 2009-07-30 Istvan Bognar Devices and Methods for Development of a Scar Tissue Tunnel Track
US8079973B2 (en) 2008-03-05 2011-12-20 Hemosphere Inc. Vascular access system
US10792413B2 (en) 2008-03-05 2020-10-06 Merit Medical Systems, Inc. Implantable and removable customizable body conduit
US20100130835A1 (en) * 2008-09-30 2010-05-27 Rox Medical, Inc. Methods for screening and treating patients with compromised cardiopulmonary function
US10070912B2 (en) * 2011-06-28 2018-09-11 Stryker European Holdings I, Llc Coupling means connecting an electrosurgical instrument to a vacuum source, an electrosurgical instrument provided with the coupling means, a kit including the coupling means and their uses
US20140142566A1 (en) * 2011-06-28 2014-05-22 Safeair Ag Coupling means connecting an electrosurgical instrument to a vacuum source, an electrosurgical instrument provided with the coupling means, a kit including the coupling means and their uses
US9278172B2 (en) 2011-09-06 2016-03-08 Cryolife, Inc. Vascular access system with connector
US11185676B2 (en) 2011-09-06 2021-11-30 Merit Medical Systems, Inc. Vascular access system with connector
US10213590B2 (en) 2011-09-06 2019-02-26 Merit Medical Systems, Inc. Vascular access system with connector
US10632296B2 (en) 2011-09-06 2020-04-28 Merit Medical Systems, Inc. Vascular access system with connector
US10034739B2 (en) 2012-06-18 2018-07-31 Board Of Regents Of The University Of Nebraska Stent to assist in arteriovenous fistula formation
US10772718B1 (en) 2012-06-18 2020-09-15 Board Of Regents Of The University Of Nebraska Stent to assist in arteriovenous fistula formation
US11701216B2 (en) 2012-06-18 2023-07-18 Board Of Regents Of The University Of Nebraska Stent to assist in arteriovenous fistula formation
US10433847B2 (en) 2013-12-17 2019-10-08 The Board Of Regents Of The University Of Nebraska Platform device and method of use to assist in anastomosis formation
US11160555B2 (en) 2013-12-17 2021-11-02 Board Of Regents Of The University Of Nebraska Platform device and method of use to assist in anastomosis formation
US10682453B2 (en) 2013-12-20 2020-06-16 Merit Medical Systems, Inc. Vascular access system with reinforcement member
WO2017046628A1 (en) 2015-09-15 2017-03-23 Koninklijke Philips N.V. Device and method for using ivus data to characterize and evaluate a vascular graft condition
US11413043B2 (en) 2016-11-10 2022-08-16 Merit Medical Systems, Inc. Anchor device for vascular anastomosis
US11383072B2 (en) 2017-01-12 2022-07-12 Merit Medical Systems, Inc. Methods and systems for selection and use of connectors between conduits
US11590010B2 (en) 2017-01-25 2023-02-28 Merit Medical Systems, Inc. Methods and systems for facilitating laminar flow between conduits
US11026704B2 (en) 2017-03-06 2021-06-08 Merit Medical Systems, Inc. Vascular access assembly declotting systems and methods
US10925710B2 (en) 2017-03-24 2021-02-23 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11622846B2 (en) 2017-03-24 2023-04-11 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods
US11179543B2 (en) 2017-07-14 2021-11-23 Merit Medical Systems, Inc. Releasable conduit connectors
US11911585B2 (en) 2017-07-20 2024-02-27 Merit Medical Systems, Inc. Methods and systems for coupling conduits
US11331458B2 (en) 2017-10-31 2022-05-17 Merit Medical Systems, Inc. Subcutaneous vascular assemblies for improving blood flow and related devices and methods

Similar Documents

Publication Publication Date Title
US3882862A (en) Arteriovenous shunt
US6053901A (en) Subcutaneously implanted cannula and method for arterial access
JP3995057B2 (en) Vascular access system for hemodialysis
US6056717A (en) Implantable vascular device
US5807356A (en) Catheter with valve
CA2040708C (en) Collapsible lumen catheter for extracorporeal treatment
US3826257A (en) Prosthetic shunt
US6042569A (en) Subcutaneously implanted cannula and methods for vascular access
US11911585B2 (en) Methods and systems for coupling conduits
US3461869A (en) Permanent skin exit device
US20060270895A1 (en) Multilumen catheter for minimizing limb ischemia
US20020188167A1 (en) Multilumen catheter for minimizing limb ischemia
US20050203457A1 (en) Apparatus and method for creating an arterio-venous connection in hemodialysis maintenance
JPH04507050A (en) Vascular access system for extracorporeal processing of blood
CN213466442U (en) ECMO femoral artery cannula capable of implementing cardiac intervention treatment
CN208448408U (en) Two-chamber jugular vein intubation both with a kind of high resiliency and flexibility
US11077239B2 (en) Tributary access device and methods of use
CN219662450U (en) Femoral artery integrated perfusion cannula
CN213964771U (en) Novel atrium catheter
US11590010B2 (en) Methods and systems for facilitating laminar flow between conduits
CN206228676U (en) A kind of vascular puncture for jugular vein central vein catheter is divided a word with a hyphen at the end of a line pin
Cole et al. Preliminary studies with the fistula catheter-a new vascular access prosthesis
Ball Forty years of vascular access.
US20220273853A1 (en) Arrangement for Transporting a Liquid Through a Cannula System, Corresponding Kit and Method
Twardowski Intravenous catheters for hemodialysis: historical perspective

Legal Events

Date Code Title Description
AS Assignment

Owner name: ING (U.S.) CORPORATION, NEW YORK

Free format text: (INVALID ASSIGNMENT);ASSIGNOR:MERIDIAN MEDICAL TECHNOLOGIES, INC.;REEL/FRAME:008186/0531

Effective date: 19961120